Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

NCT07042100

Conditions
Advanced Solid Tumors
Locations
  • Honorhealth Research Institute Scottsdale, Arizona, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • Yale University - Yale Cancer Center New Haven, Connecticut, United States
  • Hope and Healing Clinical Research LLC Hinsdale, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

NCT06818643

Conditions
Advanced Solid Tumors, Malignant Neoplasm, Neoplasms
Locations
  • The University of Alabama at Birmingham ( Site 1005) Birmingham, Alabama, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003) Miami, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 1010) Austin, Texas, United States
View all 49 locations
View Trial Details
Recruiting

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

NCT06445517

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Shanghai Jiao Tong University School of Medicine-Ruijin Hospital Shanghai, Shanghai Municipality, China
  • Tianjin Medical University Cancer Institute&Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

NCT07460375

Conditions
Advanced Solid Tumors
Locations
  • Mass General Hospital Boston, Massachusetts, United States
  • START New York - Long Island Lake Success, New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

NCT05719558

Conditions
Advanced Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Yale University Cancer Center New Haven, Connecticut, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Hospitals Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

NCT05836324

Conditions
Advanced Solid Tumors, Metastatic Solid Tumors, Solid Tumors
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer and Hematology Centers of Western Michigan-Start Midwest Grand Rapids, Michigan, United States
View all 39 locations
View Trial Details

Related conditions